These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 2579648)

  • 81. Mouse monoclonal antibodies with specificity for the melanoma-associated ganglioside disialyllactosylceramide (GD3) also react with the structural analogue disialylparagloboside.
    Brodin T; Hellström I; Hellström KE; Karlsson KA; Sjögren HO; Strömberg N; Thurin J
    Biochim Biophys Acta; 1985 Dec; 837(3):349-53. PubMed ID: 3840699
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Engineering anti-GD2 monoclonal antibodies for cancer immunotherapy.
    Ahmed M; Cheung NK
    FEBS Lett; 2014 Jan; 588(2):288-97. PubMed ID: 24295643
    [TBL] [Abstract][Full Text] [Related]  

  • 83. KIR3DL1 Allelic Polymorphism and HLA-B Epitopes Modulate Response to Anti-GD2 Monoclonal Antibody in Patients With Neuroblastoma.
    Forlenza CJ; Boudreau JE; Zheng J; Le Luduec JB; Chamberlain E; Heller G; Cheung NK; Hsu KC
    J Clin Oncol; 2016 Jul; 34(21):2443-51. PubMed ID: 27069083
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Successful multifold dose escalation of anti-GD2 monoclonal antibody 3F8 in patients with neuroblastoma: a phase I study.
    Kushner BH; Kramer K; Modak S; Cheung NK
    J Clin Oncol; 2011 Mar; 29(9):1168-74. PubMed ID: 21343563
    [TBL] [Abstract][Full Text] [Related]  

  • 85. An Optimized GD2-Targeting Retroviral Cassette for More Potent and Safer Cellular Therapy of Neuroblastoma and Other Cancers.
    Thomas S; Straathof K; Himoudi N; Anderson J; Pule M
    PLoS One; 2016; 11(3):e0152196. PubMed ID: 27030986
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Detection of gangliotriaose-series glycosphingolipids in serum of cord blood and patients with neuroblastoma by a sensitive TLC/enzyme-immunostaining method.
    Yamanaka T; Hirabayashi Y; Hirota M; Kaneko M; Matsumoto M; Kobayashi N
    Biochim Biophys Acta; 1987 Jul; 920(2):181-4. PubMed ID: 3300782
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Validated detection of anti-GD2 antibody ch14.18/CHO in serum of neuroblastoma patients using anti-idiotype antibody ganglidiomab.
    Siebert N; Seidel D; Eger C; Brackrock D; Reker D; Schmidt M; Lode HN
    J Immunol Methods; 2013 Dec; 398-399():51-9. PubMed ID: 24055592
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Human monoclonal antibody to tumor-associated ganglioside GD2.
    Katano M; Saxton RE; Irie RF
    J Clin Lab Immunol; 1984 Nov; 15(3):119-26. PubMed ID: 6099419
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Targeted interleukin-2 therapy for spontaneous neuroblastoma metastases to bone marrow.
    Lode HN; Xiang R; Varki NM; Dolman CS; Gillies SD; Reisfeld RA
    J Natl Cancer Inst; 1997 Nov; 89(21):1586-94. PubMed ID: 9362156
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Generation of a murine monoclonal antibody specific for N-glycolylneuraminic acid-containing gangliosides that also recognizes sulfated glycolipids.
    Vázquez AM; Alfonso M; Lanne B; Karlsson KA; Carr A; Barroso O; Fernández LE; Rengifo E; Lanio ME; Alvarez C
    Hybridoma; 1995 Dec; 14(6):551-6. PubMed ID: 8770642
    [TBL] [Abstract][Full Text] [Related]  

  • 91. A monoclonal antibody recognizes an O-acylated sialic acid in a human melanoma-associated ganglioside.
    Cheresh DA; Varki AP; Varki NM; Stallcup WB; Levine J; Reisfeld RA
    J Biol Chem; 1984 Jun; 259(12):7453-9. PubMed ID: 6203895
    [TBL] [Abstract][Full Text] [Related]  

  • 92. In silico driven redesign of a clinically relevant antibody for the treatment of GD2 positive tumors.
    Ahmed M; Goldgur Y; Hu J; Guo HF; Cheung NK
    PLoS One; 2013; 8(5):e63359. PubMed ID: 23696816
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Targeted radiotherapy and immunotherapy of human neuroblastoma with GD2 specific monoclonal antibodies.
    Cheung NK; Munn D; Kushner BH; Usmani N; Yeh SD
    Int J Rad Appl Instrum B; 1989; 16(2):111-20. PubMed ID: 2497088
    [No Abstract]   [Full Text] [Related]  

  • 94. Combined sialic acid and histone deacetylase (HDAC) inhibitor treatment up-regulates the neuroblastoma antigen GD2.
    van den Bijgaart RJE; Kroesen M; Wassink M; Brok IC; Kers-Rebel ED; Boon L; Heise T; van Scherpenzeel M; Lefeber DJ; Boltje TJ; den Brok MH; Hoogerbrugge PM; Büll C; Adema GJ
    J Biol Chem; 2019 Mar; 294(12):4437-4449. PubMed ID: 30670592
    [TBL] [Abstract][Full Text] [Related]  

  • 95. The specificity of monoclonal antibody A2B5 to c-series gangliosides.
    Saito M; Kitamura H; Sugiyama K
    J Neurochem; 2001 Jul; 78(1):64-74. PubMed ID: 11432974
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Immunocytochemical analysis of gangliosides in rat primary cerebellar cultures using specific monoclonal antibodies.
    Kawashima I; Nagata I; Tai T
    Brain Res; 1996 Sep; 732(1-2):75-86. PubMed ID: 8891271
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Comparison of GD2 binding capture ELISA assays for anti-GD2-antibodies using GD2-coated plates and a GD2-expressing cell-based ELISA.
    Soman G; Yang X; Jiang H; Giardina S; Mitra G
    J Immunol Methods; 2011 Oct; 373(1-2):181-91. PubMed ID: 21893062
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Involvement of Actin Filaments in the Cytotoxic Effect of GD2-Specific Antibodies.
    Doronin II; Kholodenko IV; Zubareva AA; Yarygin KN; Deev SM; Kholodenko RV
    Bull Exp Biol Med; 2019 Feb; 166(4):541-547. PubMed ID: 30783840
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Monoclonal antibodies against neuroblastoma. Production and preliminary characterization of their specificity.
    Voigt A; Häfer R; Zintl F
    J Neuroimmunol; 1993 Mar; 43(1-2):125-30. PubMed ID: 8458984
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Tetrasialoganglioside GO1b reactive monoclonal antibodies: their characterization and application for quantification of GQ1b in some cell lines of neuronal and adrenal origin(s).
    Yamamoto H; Tsuji S; Nagai Y
    J Neurochem; 1990 Feb; 54(2):513-7. PubMed ID: 2299350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.